About Us
Clinilabs is the only global, full-service contract research organization (CRO) focused exclusively on central nervous system (CNS) drug development. With deep expertise in CNS, we are committed to the development of medicines that treat a range of psychiatric, neurological, and substance use disorders, as well as rare and ultra-rare CNS diseases. Clinilabs partners with pharmaceutical and biotechnology companies to deliver a complete, first-in-human to Phase 3 spectrum of high-quality, timely, and cost-effective clinical drug development services, with the shared goal of speeding new CNS medicines to market. We are process-driven yet structured to be nimble, providing personalized service that meets the needs of customers and projects of all sizes. Clinilabs has conducted more than 750 CNS clinical trials since 2000 and has played a pivotal role in approving 22 new therapies across 13 CNS indications to help transform patients’ lives worldwide.
Our Mission
Clinilabs’ mission is to provide high-quality, prompt, and cost-effective drug and device development services to its clients in the interest of delivering new therapeutics to those in need.
Our Vision
Clinilabs’ vision is to become the leading contract research organization (CRO) dedicated to providing CNS clinical development services.
Our Culture
Clinilabs aspires to a “culture of quality” in which all our decisions and actions represent our dedication to quality in clinical development and health care.
Advances in drug development have led to greater improvement in the quality of human life than advances in all other fields combined.
Without drugs, physicians would struggle to find relevance, and patients would suffer without hope.
I trust I may be enabled in the treatment of patients always to act with a single eye to their good.
The greatest joy in life is to accomplish. It is the getting, not the having. It is the giving, not the keeping.
One sometimes finds what one is not looking for.
Good information is the best medicine.
Let me tell you the secret that has led me to my goal. My strength lies solely in my tenacity.
Drugs don’t work in patients who don’t take them.
If you think compliance is expensive, try non-compliance.
There is so much more to be done; the patients are waiting.
I am not accustomed to saying anything with certainty after only one or two observations.
Remember the Three Princes of Serendip who went out looking for treasure? They didn’t find what they were looking for, but they kept finding things just as valuable. That’s serendipity, and our business [drugs] is full of it.
The cures we want aren’t going to fall from the sky. We have to get ladders and climb up and get them.
The reward for work well done is the opportunity to do more.
One never notices what has been done; one can only see what remains to be done.
It is easy to get a thousand prescriptions, but hard to get one single remedy.
I have no ideology. My ideology is health.
All truths are easy to understand once they are discovered; the point is to discover them.
The pace of discovery is going unbelievably fast.
I must say, I spend a lot of my time these days trying to persuade people that controlled trials are the only way to get information that’s reliable about drugs.
The best way to predict the future is to invent it.